Advertisement

Quality of Life Research

, Volume 15, Issue 4, pp 695–703 | Cite as

Health-related Quality of Life, Depression and Anxiety in Thyroid Cancer Patients

  • Sefik TagayEmail author
  • Stephan Herpertz
  • Matthias Langkafel
  • Yesim Erim
  • Andreas Bockisch
  • Wolfgang Senf
  • Rainer Görges
Article

Abstract

Objectives: We examined the relationships among physical complaints, health-related quality of life (HRQL), anxiety and depression in differentiated thyroid cancer (DTC) patients under short-term hypothyroidism. Methods: We conducted a cross-sectional study in 136 patients hypothyroid on thyroid hormone withdrawal (THW) hospitalized for radioiodine administration. Patients were assessed using Short Form SF-36 (SF-36), Hospital Anxiety and Depression Scale (HADS), Profile of Mood States (POMS), Beck Depression Inventory (BDI), and physical complaints. Results: Compared to the German general population, hypothyroid patients had significantly impaired HRQL. Surprisingly, the prevalence of anxiety (62.5%), but not depression (17.9%) was much higher in hypothyroid DTC patients than in the general population. In multivariate analysis, depression and age were independently associated with the physical health score (R 2 = 0.21), but only psychological variables (depression, mood disturbance, and anxiety) were associated with the mental health score (R 2 = 0.43), on the SF-36 HRQL instrument. Conclusions: HRQL is severely impaired in DTC patients under short-term hypothyroidism. As potential predictors of generic HRQL impairment, depression, anxiety, and mood disturbance could be used to preselect the patients most needing psychiatric care. The high frequency of anxiety should be considered in the aftercare of thyroid cancer patients.

Keywords

Differentiated thyroid cancer Hypothyroidism Health-related quality of life Anxiety Depression 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aass, N, Fossa, SD, Dahl, AA, Moe, TJ 1997Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium HospitalEur J Cancer3315971604CrossRefPubMedGoogle Scholar
  2. 2.
    Broers, S, Kaptein, A, LeCessie, S, Fibbe, W, Hengeveld, MW 2000Psychological functioning and quality of life following bone marrow transplantation: A 3-year follow-up studyJ Psychosom Res481121CrossRefPubMedGoogle Scholar
  3. 3.
    Sellick, S, Crooks, D 1999Depression and cancer: An appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventionsPsycho-Oncology8315333CrossRefPubMedGoogle Scholar
  4. 4.
    Skarstein, J, Aass, N, Fossa, S, Skovlund, E, Dahl, A 2000Anxiety and depression in cancer patients: Relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life QuestionnaireJ Psychosom Res492734CrossRefPubMedGoogle Scholar
  5. 5.
    Zulewski, H, Müller, B, Exer, P, Miserez, AR, Staub, JJ 1997Estimation of tissue hypothyroidism by a new clinical score: Evaluation of patients with various grades of hypothyroidism and controlsJ Clin Endocrinol Metab82771776CrossRefPubMedGoogle Scholar
  6. 6.
    Constant, El, Volder, AG, Ivanoiu, A,  et al. 2001Cerebral blood flow and glucose metabolism in hypothyroidism: A positron emission tomography studyJ Clin Endocrinol Metab8638643870CrossRefPubMedGoogle Scholar
  7. 7.
    Ladenson, PW, Braverman, LE, Mazzaferri, EL,  et al. 1997Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinomaN Engl J Med337888896CrossRefPubMedGoogle Scholar
  8. 8.
    Meier, CA, Braverman, LE, Ebner, SA,  et al. 1994Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study)J Clin Endocrinol Metab78188196CrossRefPubMedGoogle Scholar
  9. 9.
    Dow, KH, Ferrell, BR, Anello, C 1997aQuality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapyThyroid7613619Google Scholar
  10. 10.
    Dow, K, Ferrell, B, Anello, C 1997bBalancing demands of cancer surveillance among survivors of thyroid cancerCancer Practice5289294Google Scholar
  11. 11.
    Stajduhar, KI, Neithercut, J, Chu, E,  et al. 2000Thyroid cancer: patients’ experiences of receiving iodine-131 therapyOncol Nurs Forum2712131218PubMedGoogle Scholar
  12. 12.
    Haugen, BR, Pacini, F, Reiners, C,  et al. 1999A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancerJ Clin Endocrinol Metab8438773885CrossRefPubMedGoogle Scholar
  13. 13.
    Sant, M, Aareleid, T, Berrino, F,  et al. 2003Survival of cancer patients diagnosed 1990–1994 – results and commentaryAnn Oncol14V61V118CrossRefPubMedGoogle Scholar
  14. 14.
    Schlumberger, M 1999Diagnostic follow up of well-differentiated thyroid carcinoma: historical perspective and current statusJ Endocrinol Invest2237PubMedGoogle Scholar
  15. 15.
    Cohen, O, Dabhi, S, Karasik, A, Zila Zwas, S 2004Compliance with follow-up and the informative value of diagnostic whole-body scan in patients with differentiated thyroid carcinoma given recombinant human TSHEur J Endocinol150285290CrossRefGoogle Scholar
  16. 16.
    Ware, JE, Snow, KK, Korinski, M, Gandeck, B 1993SF-36 Health Survey manual and interpretation guideNew England Medical Center, The Health InstituteBostonGoogle Scholar
  17. 17.
    Bullinger, M, Kirschberger, I, Ware, JE 1995The German SF-36 Health SurveyZ Gesundheitswissenschaft102136Google Scholar
  18. 18.
    Bullinger, M, Kirschberger, I 1998SF-36 Fragebogen zum GesundheitszustandGöttingenHogrefeGoogle Scholar
  19. 19.
    Zigmond, AS, Snaith, RP 1983The Hospital Anxiety and Depression ScaleActa Psychiatr Scand67361370PubMedGoogle Scholar
  20. 20.
    Beck, AT, Ward, CH, Mendelson, M, Mock, JE, Erbaugh, JK 1961An Inventory for measuring depressionArch Gen Psychiatry4561571PubMedGoogle Scholar
  21. 21.
    McNair, DM, Lorr, M, Droppeleman, LF 1971EITS Manual for the Profile of Mood StatesEducational and Industrial Testing ServiceSan Diego CAGoogle Scholar
  22. 22.
    Gotoy, CC, Stern, JD 1995Assessment of psychological functioning in cancer-patientsJ Psychosoc Oncol13123160CrossRefGoogle Scholar
  23. 23.
    Billewicz, WZ, Chapman, RS, Crooks, J,  et al. 1969Statistical methods applied to the diagnosis of hypothyroidismQ J Med150255266Google Scholar
  24. 24.
    Görges, R 2001The changing epidemiology of thyroid cancerBiersack, HJGrünwald, F eds. Thyroid CancerSpringerHeidelbergGoogle Scholar
  25. 25.
    Botella-Carretero, JI, Galán, JM, Caballero, C, Sanco, J, Escobar-Morreale, HF 2004Quality of life and psychometric functionality in patients with differentiated thyroid carcinomaEndocrine-Related Cancer10601610CrossRefGoogle Scholar
  26. 26.
    Crevenna, R, Zettinig, G, Keilani, M,  et al. 2004Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapySupport Care Cancer11597603CrossRefGoogle Scholar
  27. 27.
    Tate, DF, Riley, BB, Perna, R, Roler, S 1997Quality of life issues among women with physical disabilities or breast cancerArch Phys Med Rehabil781825CrossRefGoogle Scholar
  28. 28.
    Bullinger, M 1995German translation and psychometric testing of the SF-36 Health Survey: Preliminary results from the IQOLA ProjectSoc Sci Med4113591366CrossRefPubMedGoogle Scholar
  29. 29.
    Liu, L, Meers, K, Capurso, A, Engebretson, T, Glicksman, A 1998The impact of radiation therapy on quality of life in patients with cancerCancer Practice6237242CrossRefPubMedGoogle Scholar
  30. 30.
    Sachar, EJ 1995Psychiatric disturbances associated with endocrine disordersFreedman, DXDyrud, JE eds. American Handbook of PsychiatryBasic BooksNew York299313Google Scholar
  31. 31.
    Maher, EJ, Mackenzie, C, Young, T, Marks, D 1996The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaire to screen for treatable unmet needs in patients attending routinely for radiotherapyCancer Treat Rev22123129CrossRefPubMedGoogle Scholar
  32. 32.
    Fossa, SD, Dahl, AA 2002Short Form 36 and Hospital Anxiety and Depression Scale – a comparison based on patients with testicular cancerJ Psychosom Res527987CrossRefPubMedGoogle Scholar
  33. 33.
    Dugbartey, AT 1998Neurocognitive aspects of hypothyroidismArch Intern Med15814131418CrossRefPubMedGoogle Scholar
  34. 34.
    Larisch, R, Kley, K, Nikolaus, S,  et al. 2004Depression and anxiety in different function statesHorm Metab Res36650653CrossRefPubMedGoogle Scholar
  35. 35.
    Fischer, DA 1996Physiological variations in thyroid hormones: Physiological and pathophysiological considerationsClin Chem42135139Google Scholar
  36. 36.
    Hirsberg, B, Veldhuis, JD, Sarlis, NJ 2000Diurnal thyrotropin secretion in short-term profound primary hypothyroidism: Does it ever persist?Thyroid1011011106CrossRefGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • Sefik Tagay
    • 1
    Email author
  • Stephan Herpertz
    • 2
  • Matthias Langkafel
    • 1
  • Yesim Erim
    • 1
  • Andreas Bockisch
    • 3
  • Wolfgang Senf
    • 1
  • Rainer Görges
    • 3
  1. 1.Clinic of Psychosomatic Medicine and PsychotherapyUniversity of Duisburg-EssenEssenGermany
  2. 2.Department of Psychosomatic Medicine and PsychotherapyRuhr-UniversityBochumGermany
  3. 3.Department of Nuclear MedicineUniversity of Duisburg-EssenEssenGermany

Personalised recommendations